2022 Form 10-K Financial Statement

#000141057822001878 Filed on June 15, 2022

View on sec.gov

Income Statement

Concept 2022 2021 Q1 2021
Revenue $5.000K $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $309.0K $10.00K $26.50K
YoY Change 1066.19% -35.73% -36.01%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $309.0K $10.00K $26.50K
YoY Change 1066.3% -33.73% -36.01%
Operating Profit -$304.0K -$26.50K
YoY Change 1047.43%
Interest Expense $1.699M
YoY Change
% of Operating Profit
Other Income/Expense, Net -$1.769M
YoY Change
Pretax Income -$2.073M -$10.00K -$26.50K
YoY Change 7724.11% -33.73% -36.01%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$2.073M -$10.00K -$26.50K
YoY Change 7725.0% -33.73% -36.01%
Net Earnings / Revenue -41467.8%
Basic Earnings Per Share -$0.36 $0.00
Diluted Earnings Per Share -$0.36 -$2.950K $0.00
COMMON SHARES
Basic Shares Outstanding 5.753M 3.513M
Diluted Shares Outstanding 5.753M 3.513M

Balance Sheet

Concept 2022 2021 Q1 2021
SHORT-TERM ASSETS
Cash & Short-Term Investments $180.8K $0.00 $80.00
YoY Change 225850.0% -100.0% -73.33%
Cash & Equivalents $75.00
Short-Term Investments
Other Short-Term Assets $32.21K
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $213.0K $0.00 $80.00
YoY Change 266100.0% -100.0% -73.33%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $75.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $213.0K $0.00 $80.00
Total Long-Term Assets $0.00 $75.00 $0.00
Total Assets $213.0K $75.00 $80.00
YoY Change 266100.0% -75.0% -73.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $13.48K $270.0K $271.2K
YoY Change -95.03% 9.81% 10.28%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $2.160M $2.160M
YoY Change -100.0% 0.06% 0.05%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $13.48K $2.436M $2.436M
YoY Change -99.45% 1.09% 1.09%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $13.48K $2.436M $2.436M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $13.48K $2.436M $2.436M
YoY Change -99.45% 1.09% 1.09%
SHAREHOLDERS EQUITY
Retained Earnings -$5.120M
YoY Change
Common Stock $35.53K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $42.45K
YoY Change
Treasury Stock Shares $39.98K
Shareholders Equity $199.5K -$2.436M -$2.436M
YoY Change
Total Liabilities & Shareholders Equity $213.0K $75.00 $80.00
YoY Change 266100.0% -75.0% -73.33%

Cashflow Statement

Concept 2022 2021 Q1 2021
OPERATING ACTIVITIES
Net Income -$2.073M -$10.00K -$26.50K
YoY Change 7725.0% -33.73% -36.01%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$118.0K $1.080K -$1.226K
YoY Change 9523.9% -134.95% -94.94%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $240.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 298.7K 0.000 1.000K
YoY Change 29767.0% -100.0% -95.88%
NET CHANGE
Cash From Operating Activities -118.0K 1.080K -1.226K
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities 298.7K 0.000 1.000K
Net Change In Cash 180.7K 1.080K -226.0
YoY Change -80047.35% -417.65%
FREE CASH FLOW
Cash From Operating Activities -$118.0K $1.080K -$1.226K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 us-gaap Assets
Assets
75
CY2022Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
13478
CY2021Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
271158
CY2021Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
5127
CY2021Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
2159631
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
13478
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2435916
CY2022Q1 us-gaap Liabilities
Liabilities
13478
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--02-28
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.36
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5752866
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3512527
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1105679
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0000764630
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Trading Symbol
TradingSymbol
USBL
CY2022 dei Entity Registrant Name
EntityRegistrantName
UNITED STATES BASKETBALL LEAGUE INC
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-02-28
CY2022 dei Entity File Number
EntityFileNumber
001-15913
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
06-1120072
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
8270 Woodland Center
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Tampa
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33614
CY2022 dei City Area Code
CityAreaCode
813
CY2022 dei Local Phone Number
LocalPhoneNumber
769-3500
CY2022 dei Security12g Title
Security12gTitle
Common Stock , $.01 par value
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2020Q3 dei Entity Public Float
EntityPublicFloat
2270124
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8845348
CY2022 dei Auditor Firm
AuditorFirmId
6631
CY2022 dei Auditor Name
AuditorName
QI CPA LLC
CY2022 dei Auditor Location
AuditorLocation
Valley Stream, New York
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
180756
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
75
CY2022Q1 usbl Prepaid Expense For Services Current
PrepaidExpenseForServicesCurrent
32208
CY2022Q1 us-gaap Assets
Assets
212964
CY2021Q1 us-gaap Liabilities
Liabilities
2435916
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1105679
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
11057
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8845348
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3552502
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
88453
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
35525
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7346701
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2679855
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7193214
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5119824
CY2021Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
39975
CY2022Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
39975
CY2022Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
42454
CY2021Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
42454
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
199486
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-2435841
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
212964
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
75
CY2022 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
5000
CY2022 us-gaap Professional Fees
ProfessionalFees
31551
CY2021 us-gaap Professional Fees
ProfessionalFees
13750
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
229484
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12747
CY2022 us-gaap Other Expenses
OtherExpenses
48000
CY2022 us-gaap Operating Expenses
OperatingExpenses
309035
CY2021 us-gaap Operating Expenses
OperatingExpenses
26497
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-304035
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-26497
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
55270
CY2022 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
2000
CY2022 us-gaap Interest Expense
InterestExpense
1699145
CY2022 usbl Loss On Conversion Of Debt Related Party
LossOnConversionOfDebtRelatedParty
127480
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1769355
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-2073390
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-26497
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.36
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5752866
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3512527
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-2409344
CY2021 us-gaap Profit Loss
ProfitLoss
-26497
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-2435841
CY2022 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
48000
CY2022 usbl Stock Issued During Period Value Forgiveness Of Related Party Debt
StockIssuedDuringPeriodValueForgivenessOfRelatedPartyDebt
-2346971
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
215250
CY2022 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
240000
CY2022 usbl Common Stock Issued For Loans Payable Related Party
CommonStockIssuedForLoansPayableRelatedParty
159350
CY2022 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1699146
CY2022 us-gaap Profit Loss
ProfitLoss
-2073390
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
199486
CY2022 us-gaap Profit Loss
ProfitLoss
-2073390
CY2021 us-gaap Profit Loss
ProfitLoss
-26497
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
55270
CY2022 usbl Loss On Conversion Of Debt Related Party
LossOnConversionOfDebtRelatedParty
127480
CY2022 us-gaap Interest Expense
InterestExpense
1699145
CY2022 usbl Common Stock Granted For Director Fees
CommonStockGrantedForDirectorFees
-48000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
183043
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-46997
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
25271
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-117989
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1226
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0
CY2022 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
58670
CY2021 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
1000
CY2022 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
3581
CY2022 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
3581
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
240000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
298670
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
180681
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-226
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
75
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
301
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
180756
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
75
CY2022 us-gaap Interest Paid Net
InterestPaidNet
0
CY2021 us-gaap Interest Paid Net
InterestPaidNet
0
CY2022 usbl Related Party Loans Converted To Common Stock
RelatedPartyLoansConvertedToCommonStock
31870
CY2021 usbl Related Party Loans Converted To Common Stock
RelatedPartyLoansConvertedToCommonStock
0
CY2022 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
1984-05-29
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt;"><i style="text-decoration-line:underline;text-decoration-style:solid;">Use of Estimates</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company’s accounting estimates include the collectability of receivables, useful lives of long-lived assets and recoverability of those assets, impairment in fair value of goodwill, valuation allowances for income taxes, stock-based compensation.</p>
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt;"><i style="text-decoration-line:underline;text-decoration-style:solid;">Concentration of Credit Risk</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">We maintain our cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. We continually monitor our banking relationships and consequently have not experienced any losses in our accounts. We believe we are not exposed to any significant credit risk on cash.</p>
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7193214
CY2021Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
101424
CY2021Q1 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
8660
CY2021Q1 us-gaap Accrued Rent Current
AccruedRentCurrent
144000
CY2021Q1 us-gaap Interest Payable Current
InterestPayableCurrent
13562
CY2021Q1 us-gaap Deposits
Deposits
2725
CY2021Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
777
CY2021Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
271158
CY2021Q1 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
2159631
CY2021Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
55270
CY2022 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
5000
CY2022Q1 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
3581
CY2022Q1 usbl Number Of Preferred Stock Voting Rights
NumberOfPreferredStockVotingRights
5
CY2022 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.02
CY2022Q1 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
1
CY2022 us-gaap Interest Expense
InterestExpense
1699145
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.21
CY2022Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
295000
CY2021Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
279500
CY2021Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
561500
CY2022Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
295000
CY2021Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
282000
CY2022 usbl Effective Income Tax Rate Reconciliation Book Loss
EffectiveIncomeTaxRateReconciliationBookLoss
435400
CY2021 usbl Effective Income Tax Rate Reconciliation Book Loss
EffectiveIncomeTaxRateReconciliationBookLoss
5600
CY2022 usbl Effective Income Tax Rate Reconciliation Related Party Accruals
EffectiveIncomeTaxRateReconciliationRelatedPartyAccruals
453500
CY2021 usbl Effective Income Tax Rate Reconciliation Related Party Accruals
EffectiveIncomeTaxRateReconciliationRelatedPartyAccruals
-200
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
341700
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
547200
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
5400
CY2022Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1135000
CY2022 usbl Operating Loss Carryforwards Expiration Period
OperatingLossCarryforwardsExpirationPeriod
P20Y
CY2022 usbl Operating Loss Carryforwards Carryback Period Cares Act
OperatingLossCarryforwardsCarrybackPeriodCaresAct
P5Y
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0

Files In Submission

Name View Source Status
0001410578-22-001878-index-headers.html Edgar Link pending
0001410578-22-001878-index.html Edgar Link pending
0001410578-22-001878.txt Edgar Link pending
0001410578-22-001878-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
usbl-20220228.xsd Edgar Link pending
usbl-20220228x10k.htm Edgar Link pending
usbl-20220228x10k_htm.xml Edgar Link completed
usbl-20220228xex31d1.htm Edgar Link pending
usbl-20220228xex32d1.htm Edgar Link pending
usbl-20220228_cal.xml Edgar Link unprocessable
usbl-20220228_def.xml Edgar Link unprocessable
usbl-20220228_lab.xml Edgar Link unprocessable
usbl-20220228_pre.xml Edgar Link unprocessable